-
Mashup Score: 0
A new MIT sensor can distinguish between viral and bacterial pneumonia infections. This could help doctors choose the appropriate treatment and avoid prescribing antibiotics when they won’t help.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Just one dose of a new COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines in use. With minor changes, the same platform may target other infectious diseases.
Source: news.northwestern.eduCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Cancer News Daily - 2 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7
Researchers designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed it significantly improved antibody production following vaccination against HIV, diphtheria and influenza.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 34Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles - 3 year(s) ago
Limited understanding of the interactions between nanoparticle drug carriers and the blood-brain barrier underlies many translational failures in treatments of brain disorders. Here the authors use two-photon microscopy in mice to characterize the receptor-mediated transcytosis of nanoparticles at all steps of delivery from the blood to the brain in vivo.
Source: Nature CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Discussing Nanoparticle and Adenovirus Vaccine Platforms - 3 year(s) ago
A Q&A surrounding the two technologies with investigators from the Wistar Institute.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 6
Scientists propose an innovative vaccine approach to protect against a troublesome family of viruses that present a major global health risk. May 11, 2021 LA JOLLA, CA—Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to threaten…
Source: www.scripps.eduCategories: General Medicine News, Latest HeadlinesTweet
#Nanoparticle #sensor can distinguish between viral and bacterial #pneumonia - Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective. | #AMR #research https://t.co/le3Czhpw8m